These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23995996)

  • 1. Direct thrombolytic therapy for thrombosis of a centrifugal flow left ventricular assist device.
    Jabbar AA; Yau R; Frazier OH; Delgado R
    ASAIO J; 2013; 59(5):530-2. PubMed ID: 23995996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.
    Muthiah K; Robson D; Macdonald PS; Keogh AM; Kotlyar E; Granger E; Dhital K; Spratt P; Jansz P; Hayward CS
    Artif Organs; 2013 Mar; 37(3):313-8. PubMed ID: 23373528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
    Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
    J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device.
    Delgado R; Frazier OH; Myers TJ; Gregoric ID; Robertson K; Shah NA; Kar B
    J Heart Lung Transplant; 2005 Feb; 24(2):231-3. PubMed ID: 15701444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failed repeated thrombolysis requiring left ventricular assist device pump exchange.
    Tang GH; Kim MC; Pinney SP; Anyanwu AC
    Catheter Cardiovasc Interv; 2013 May; 81(6):1072-4. PubMed ID: 22718366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis in Continuous Flow Left Ventricular Assist Devices: Our Clinical Experience With Medical and Surgical Management.
    Köksel U; Erbasan O; Bayezid Ö; Kemaloğlu C; Özçobanoğlu S; Gölbaşı I; Türkay C
    Transplant Proc; 2016; 48(6):2162-7. PubMed ID: 27569964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices.
    Schlendorf K; Patel CB; Gehrig T; Kiefer TL; Felker GM; Hernandez AF; Blue LJ; Milano CA; Rogers JG
    J Card Fail; 2014 Feb; 20(2):91-7. PubMed ID: 24361803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative approaches for HeartWare ventricular assist device pump thrombosis may improve the outcome compared with immediate surgical approaches.
    Saeed D; Maxhera B; Albert A; Westenfeld R; Hoffmann T; Lichtenberg A
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):90-5. PubMed ID: 26993475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective treatment with a new protocol using tissue-type plasminogen activator thrombolysis for pump thrombosis with the HVAD device.
    Schrage B; Grahn H; Wagner FM; Bernhardt A; Rybczynski M; Blankenberg S; Reichenspurner H; Barten MJ
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):766-770. PubMed ID: 28058856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel application of Angiojet rheolytic thrombectomy for massive thrombosis of the native aortic valve and Jarvick 2000 ventricular assist device in a patient with end-stage heart failure.
    Barbieri A; Bertelli L; Sangiorgi GM
    Catheter Cardiovasc Interv; 2011 Nov; 78(6):958-61. PubMed ID: 21805566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved left ventricular unloading and circulatory support with synchronized pulsatile left ventricular assistance compared with continuous-flow left ventricular assistance in an acute porcine left ventricular failure model.
    Letsou GV; Pate TD; Gohean JR; Kurusz M; Longoria RG; Kaiser L; Smalling RW
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1181-8. PubMed ID: 20546799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of increases in pump power use and associated clinical outcomes with an axial continuous-flow ventricular assist device.
    Steffen RJ; Soltesz EG; Miracle K; Lee S; Mountis M; Moazami N
    J Heart Lung Transplant; 2014 Jan; 33(1):105-6. PubMed ID: 24418736
    [No Abstract]   [Full Text] [Related]  

  • 16. Biventricular circulatory support with two miniaturized implantable assist devices.
    Krabatsch T; Potapov E; Stepanenko A; Schweiger M; Kukucka M; Huebler M; Hennig E; Hetzer R
    Circulation; 2011 Sep; 124(11 Suppl):S179-86. PubMed ID: 21911810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device System: A Novel Approach Using Log File Analysis.
    Jorde UP; Aaronson KD; Najjar SS; Pagani FD; Hayward C; Zimpfer D; Schlöglhofer T; Pham DT; Goldstein DJ; Leadley K; Chow MJ; Brown MC; Uriel N
    JACC Heart Fail; 2015 Nov; 3(11):849-56. PubMed ID: 26454842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of left ventricular assist device thrombosis with extended catheter-directed intraventricular thrombolytic therapy.
    Thenappan T; Anderson AS; Jeevanadham V; Rich JD; Shah AP
    Circ Heart Fail; 2013 May; 6(3):e27-9. PubMed ID: 23694774
    [No Abstract]   [Full Text] [Related]  

  • 19. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
    Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
    J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.